Davidar David D's Form 4 filing
Globus Medical Inc (GMED) · filed Nov 25, 2024
- Accession no.
- 0000950170-24-130603
- Filed
- Nov 25, 2024
- Trade date
- Nov 21-22, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.40M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davidar David DCIK 0001555268 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | Class A Common Stock | SSaleDisposed | −13,234 | $85.00 | −$1,124,890 | 523,041 | Direct | |
| Nov 21, 2024 | Class A Common Stock | SSaleDisposed | −13,254 | $85.00 | −$1,126,590 | 172,713 | Indirect | |
| Nov 22, 2024 | Class A Common Stock | SSaleDisposed | −6,766 | $85.00 | −$575,110 | 516,275 | Direct | |
| Nov 22, 2024 | Class A Common Stock | SSaleDisposed | −6,746 | $85.00 | −$573,410 | 165,967 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.